علاج ثوري بالخلايا الجذعية يحرر مرضى السكري من الأنسولين

Scientists have achieved a significant breakthrough in the treatment of type 1 diabetes by developing a therapy using programmed stem cells capable of producing insulin within the body, thus eliminating the need for daily injections for patients. The results of the trials showed that 70% of the patients completely stopped using insulin, while the required doses for the rest were significantly reduced.

The treatment relies on implanting pancreatic cells that produce the hormone insulin, derived from stem cells taken from the patient themselves, which reduces the chances of immune rejection. Researchers hope that the treatment will be widely available within two years after the completion of final clinical trials.

This breakthrough is considered one of the most important achievements in diabetes treatment, as it targets the root causes of the disease rather than just managing its symptoms. It also provides a higher quality of life for those affected and alleviates the chronic complications associated with long-term illness.